Concord Biotech has informed regarding the successful completion of the European Union Good Manufacturing Practice (EU GMP) inspection at Active Pharmaceutical Ingredient (API) manufacturing facility located in Dholka, Gujarat. The inspection was conducted from July 14’ 2025 to July 18’ 2025. This achievement underscores its unwavering commitment to upholding the highest standards of quality, safety, and regulatory compliance across all aspects of its operations. It reflects its dedication to excellence and its continued focus on meeting the rigorous requirements of global regulatory authorities.
The above information is a part of company’s filings submitted to BSE.
| Company Name | CMP |
|---|---|
| Sun Pharma Inds. | 1668.75 |
| Dr. Reddys Lab | 1233.95 |
| Cipla | 1231.60 |
| Zydus Lifesciences | 938.70 |
| Lupin | 2328.25 |
| View more.. | |
MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.
To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.
MoneyWorks4Me ensures this through: